UBS Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278M | Buy |
|
|||||
|
2025
Q1 | $18.9M | Buy |
|
|||||
|
2024
Q4 | $17.2M | Buy |
|
|||||
|
2024
Q3 | $10.9M | Buy |
|
|||||
|
2024
Q2 | $9.12M | Sell |
|
|||||
|
2024
Q1 | $11.9M | Sell |
|
|||||
|
2023
Q4 | $11.7M | Buy |
|
|||||
|
2023
Q3 | $3.27M | Sell |
|
|||||
|
2023
Q2 | $5.17M | Sell |
|
|||||
|
2023
Q1 | $3.81M | Sell |
|
|||||
|
2022
Q4 | $5.91M | Buy |
|
|||||
|
2022
Q3 | $619K | Sell |
|
|||||
|
2022
Q2 | $1.68M | Sell |
|
|||||
|
2022
Q1 | $3.09M | Sell |
|
|||||
|
2021
Q4 | $6.89M | Buy |
|
|||||
|
2021
Q3 | $5.42M | Buy |
|
|||||
|
2021
Q2 | $1.81M | Sell |
|
|||||
|
2021
Q1 | $6.33M | Buy |
|
|||||
|
2020
Q4 | $1.98M | Buy |
|
|||||
|
2020
Q3 | $510K | Sell |
|
|||||
|
2020
Q2 | $683K | Buy |
|
|||||
|
2020
Q1 | $238K | Sell |
|
|||||
|
2019
Q4 | $1.95M | Sell |
|
|||||
|
2019
Q3 | $4.4M | Buy |
|
|||||
|
2019
Q2 | $53K | Buy |
|
|||||
|
2019
Q1 | $27K | Sell |
|
|||||
|
2018
Q4 | $1.84M | Buy |
|
|||||
|
2018
Q3 | $1.78M | Buy |
|
|||||
|
2018
Q2 | $25K | Sell |
|
|||||
|
2018
Q1 | $5.21M | Buy |
|
|||||
|
2017
Q4 | $1.28M | Sell |
|
|||||
|
2017
Q3 | $2.33M | Buy |
|
|||||
|
2017
Q2 | $1.16M | Buy |
|
|||||
|
2017
Q1 | $293K | Sell |
|
|||||
|
2016
Q4 | $360K | Buy |
|
|||||
|
2016
Q3 | $98K | Buy |
|
|||||
|
2016
Q2 | $58K | Sell |
|
|||||
|
2016
Q1 | $158K | Buy |
|
|||||
|
2015
Q4 | $223K | Buy |
|
|||||
|
2015
Q3 | $178K | Buy |
|
|||||
|
2015
Q2 | $207K | Buy |
|